Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease
Authors
Keywords
-
Journal
JAMA Cardiology
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-08-03
DOI
10.1001/jamacardio.2022.2333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advancing Beyond Failed HDL Clinical Trials to Pharmacogenetic Studies of ADCY9 and CETP inhibition
- (2021) Donald M. Black et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
- (2021) Urmo Võsa et al. NATURE GENETICS
- Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population
- (2021) Liv Tybjærg Nordestgaard et al. JAMA Cardiology
- Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
- (2020) Gregory G. Schwartz et al. DIABETES CARE
- Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
- (2020) Eric Bruckert et al. ADVANCES IN THERAPY
- Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial
- (2020) Venu Menon et al. BMJ Open Diabetes Research & Care
- PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks
- (2020) Tim Hollstein et al. American Journal of Cardiovascular Drugs
- What is ‘LDL cholesterol’?
- (2019) Michael V. Holmes et al. Nature Reviews Cardiology
- Factorial Mendelian randomization: using genetic variants to assess interactions
- (2019) Jessica M B Rees et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. ATHEROSCLEROSIS
- Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mendelian randomization analysis of cholesteryl ester transfer protein and subclinical atherosclerosis: A population-based study
- (2018) Tim Christen et al. Journal of Clinical Lipidology
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile
- (2018) Lisanne L. Blauw et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The UK Biobank resource with deep phenotyping and genomic data
- (2018) Clare Bycroft et al. NATURE
- Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration
- (2018) Johanna M. Colijn et al. OPHTHALMOLOGY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
- (2017) Amand F Schmidt et al. Lancet Diabetes & Endocrinology
- Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations
- (2017) Bram P. Prins et al. Scientific Reports
- Comparison of variance estimators for meta-analysis of instrumental variable estimates
- (2016) A.F. Schmidt et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
- (2016) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
- (2016) Johannes Kettunen et al. Nature Communications
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
- (2015) Majid Nikpay et al. NATURE GENETICS
- Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib
- (2012) Michael Davidson et al. JOURNAL OF LIPID RESEARCH
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
- (2009) M. J. Chapman et al. EUROPEAN HEART JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started